Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature Communications vol. 16, no. 1 (2025), p. 1378
Veröffentlicht:
Nature Publishing Group
Schlagworte:
Online-Zugang:Citation/Abstract
Full Text - PDF
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

MARC

LEADER 00000nab a2200000uu 4500
001 3163630687
003 UK-CbPIL
022 |a 2041-1723 
024 7 |a 10.1038/s41467-025-56347-2  |2 doi 
035 |a 3163630687 
045 2 |b d20250101  |b d20251231 
084 |a 145839  |2 nlm 
245 1 |a Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche 
260 |b Nature Publishing Group  |c 2025 
513 |a Journal Article 
520 3 |a Metastasis in cancer is influenced by epigenetic factors. Using an in vivo screen, we demonstrate that several subunits of the polybromo-associated BAF (PBAF) chromatin remodeling complex, particularly Brd7, are required for maintaining breast cancer metastatic dormancy in the lungs of female mice. Brd7 loss induces metastatic reawakening, along with modifications in epigenomic landscapes and upregulated oncogenic signaling. Breast cancer cells harboring Brd7 inactivation also reprogram the surrounding immune microenvironment by downregulating MHC-1 expression and promoting a pro-metastatic cytokine profile. Flow cytometric and single-cell analyses reveal increased levels of pro-tumorigenic inflammatory and transitional neutrophils, CD8+ exhausted T cells, and CD4+ stress response T cells in lungs from female mice harboring Brd7-deficient metastases. Finally, attenuating this immunosuppressive milieu by neutrophil depletion, neutrophil extracellular trap (NET) inhibition, or immune checkpoint therapy abrogates metastatic outgrowth. These findings implicate Brd7 and PBAF in triggering metastatic outgrowth in cancer, pointing to targetable underlying mechanisms involving specific immune cell compartments.Metastasis-initiating cells can reawaken from a dormant state that initially allowed them to survive, triggering metastatic outgrowth. Here, authors show that loss of Brd7 promotes an immunosuppressive tumor microenvironment that drives breast cancer metastatic reawakening from dormancy in the lung. 
653 |a Neutrophils 
653 |a Metastasis 
653 |a Lungs 
653 |a Immune system 
653 |a Breast cancer 
653 |a Lymphocytes T 
653 |a Lung cancer 
653 |a Leukocytes (neutrophilic) 
653 |a Immune checkpoint 
653 |a Epigenetics 
653 |a Females 
653 |a Major histocompatibility complex 
653 |a Tumor microenvironment 
653 |a Chromatin remodeling 
653 |a Dormancy 
653 |a Flow cytometry 
653 |a Metastases 
653 |a Cellular stress response 
653 |a CD4 antigen 
653 |a CD8 antigen 
653 |a Lymphocytes 
653 |a Social 
773 0 |t Nature Communications  |g vol. 16, no. 1 (2025), p. 1378 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3163630687/abstract/embedded/L8HZQI7Z43R0LA5T?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3163630687/fulltextPDF/embedded/L8HZQI7Z43R0LA5T?source=fedsrch